Manning Paul B 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-21 4:01 pm Purchase | 2023-08-16 | 13D | Taysha Gene Therapies, Inc. TSHA | Manning Paul B | 23,476,333 12.600% | 16,486,472 (+235.86%) | Filing |
| 2022-11-02 4:02 pm Purchase | 2022-10-31 | 13D | Taysha Gene Therapies, Inc. TSHA | Manning Paul B | 6,989,861 11.200% | 1,694,554 (+32.00%) | Filing |
| 2020-10-05 5:26 pm Purchase | 2020-09-23 | 13D | Taysha Gene Therapies, Inc. TSHA | Manning Paul B | 5,295,307 14.300% | 5,295,307 (New Position) | Filing |